Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Non-Malignant Channel:
Thalassemia

Explore the latest updates and expert interviews

The Thalassemia Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Latest videos Conferences Topics Sessions Features Podcasts Expert Editorial Board

Welcome to The Thalassemia Channel. 

Delve into the latest updates in alpha and beta thalassemia by exploring our Thalassemia Channel, which brings you video interviews, podcasts, expert-led discussions, and more.

The Thalassemia Channel provides you with the latest in the field, including novel therapies being explored, updates in disease biology, and ongoing clinical trials.

Conferences

ESH Erythro 2025
ASCAT 2024
EHA 2024
BSH 2024
EBMT 2024
ASH 2023
2:21
The impact of ineffective erythropoiesis in hemoglobinopathies & underlying mechanisms
Sara El Hoss • 21 Mar 2025
2:03
Potential therapeutic avenues being explored to target inflammation in thalassemia & SCD
Francesca Vinchi • 21 Mar 2025
2:23
The pathophysiology of inflammation in beta thalassemia and SCD
Francesca Vinchi • 21 Mar 2025
3:09
The potential benefit of combining luspatercept with iron restriction compounds in MDS & thalassemia
Francesca Vinchi • 21 Mar 2025
View All Videos
2:23
The history of improving outcomes in thalassemia and the importance of the multidisciplinary team
Malcolm Walker • 2 Oct 2024
2:29
Transplant-related toxicity in pediatric patients with SCD or thalassemia
Jean-Hugues Dalle • 3 Oct 2024
2:06
Addressing the growth and development challenges in thalassemia
Maddalena Casale • 15 Oct 2024
4:20
The lack of psychosocial support for patients with thalassemia and SCD
Maya Bizri • 4 Oct 2024
View All Videos
3:49
The impact of alloSCT versus blood transfusion & iron chelation on the QoL of patients with TDT
Tsampika Vasileia Kalamara • 27 Jun 2024
1:14
The challenges associated with treating patients with non-transfusion-dependent thalassemia
Ali Taher • 15 Jun 2024
2:08
Challenges associated with gene therapies for SCD and thalassemia
Subarna Chakravorty • 16 Jun 2024
1:29
Updates from the ENERGIZE study of mitapivat in non-transfusion-dependent alpha-/beta-thalassemia
Ali Taher • 15 Jun 2024
View All Videos
2:40
What can clinicians do to address the impact of transfusion-dependent thalassemia on patients’ QoL?
Farrukh Shah • 30 Apr 2024
2:27
Optimizing the delivery of care for patients with hemoglobinopathies in the UK
Farrukh Shah • 30 Apr 2024
2:46
Morbidity and mortality data from the UK National Haemoglobinopathy Registry
Farrukh Shah • 30 Apr 2024
View All Videos
1:46
Treosulfan versus busulfan-based conditioning for HSCT in transfusion-dependent thalassemia
Rita Beier • 15 Apr 2024
2:01
The MDT in the new era of gene therapy for hemoglobinopathies
Mattia Algeri • 15 Apr 2024
2:18
A global view of transfusion-dependent thalassemia: standard of care, outcomes, and unmet needs
Ali Taher • 15 Apr 2024
View All Videos
1:43
Approval of exa-cel for SCD
Haydar Frangoul • 14 Dec 2023
1:58
Manipulating immune targeting of solid tumors with gene therapy
Akshat Jain • 8 Dec 2023
1:39
Luspatercept in patients with HbE/β‑thalassemia: a subgroup analysis from the BELIEVE study
Kevin Kuo • 10 Dec 2023
11:42
Thalassemia highlights at ASH 2023: novel therapies, trial updates & the value of precision medicine
Kevin Kuoet al. • 11 Dec 2023
View All Videos

Topics

Treatment
Disease biology
Trial updates
Immuno-oncology
Transplantation
2:16
The management of thalassemia in India
Shruti Kakkar • 15 Oct 2025
2:33
The potential role of thalidomide in the treatment of thalassemia
Shruti Kakkar • 15 Oct 2025
3:10
Past studies that have assessed the safety and efficacy of thalidomide in thalassemia
Shruti Kakkar • 15 Oct 2025
9:38
The potential of mitapivat in thalassemia: results of the ENERGIZE and ENERGIZE-T trials
Maria Domenica Cappellini • 8 Oct 2025
View All Videos
2:39
The mechanism of action and rationale for using thalidomide in thalassemia
Shruti Kakkar • 15 Oct 2025
4:24
Examining the morbidity rate in adults with NTDT referred to US specialty centers
Aaron Cheng • 20 Oct 2025
2:20
The repurposing of drugs for the treatment of sickle cell disease, with a focus on luspatercept
Thiago Trovati Maciel • 17 Oct 2025
2:39
Managing acute complications of thalassemia that may present to the emergency department
Ali Taher • 20 Oct 2025
View All Videos
9:38
The potential of mitapivat in thalassemia: results of the ENERGIZE and ENERGIZE-T trials
Maria Domenica Cappellini • 8 Oct 2025
2:31
Long-term follow-up of the BEYOND trial: luspatercept in non-transfusion dependent thalassemia
Ali Taher • 20 Oct 2025
4:12
ENERGIZE-T: a Phase III study of mitapivat in transfusion-dependent alpha- or beta-thalassemia
Maria Domenica Cappellini • 7 Dec 2024
1:46
Iron overload parameters in transfusion-dependent β-thalassemia treated with luspatercept
Maria Domenica Cappellini • 7 Dec 2024
View All Videos
5:14
Advances in the treatment of SCD & thalassemia: luspatercept, mitapivat, gene therapy, and more
Maria Domenica Cappellini • 18 Mar 2025
1:58
Manipulating immune targeting of solid tumors with gene therapy
Akshat Jain • 8 Dec 2023
3:04
Session highlights: top abstracts in red cell disorders
Subarna Chakravorty • 24 Apr 2023
2:13
Nursing track: pharmacy updates
Susie Long • 9 Feb 2023
View All Videos
10:55
Transplantation and gene therapy in SCD and thalassemia: donor types and indications
Subarna Chakravorty • 3 Nov 2025
2:39
The mechanism of action and rationale for using thalidomide in thalassemia
Shruti Kakkar • 15 Oct 2025
3:21
The selection of patients with transfusion-dependent thalassemia for alloSCT or gene therapy
Mattia Algeri • 31 Mar 2025
4:08
The main benefits and challenges of gene therapy for sickle cell disease
Akshay Sharma • 9 Apr 2025
View All Videos

The Thalassemia Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Gold Supporter

Agios

If you are interested in becoming a supporter of The Thalassemia Channel, please contact us.

The content of VJHemOnc is intended for healthcare professionals